Related Experiment Videos
The congenital dyserythropoietic anaemias
1INSERM U 473, Hôpital de Bicêtre, Faculté de Médecine Paris-Sud, Le Kremlin-Bicêtre, France. delaunay@kb.inserm.fr
Insights
Congenital dyserythropoietic anaemias (CDA) are rare genetic disorders affecting red blood cell production. Recent gene localization advances enable epidemiological studies for these complex anemias.
Area of Science:
- Hematology
- Genetics
- Rare Diseases
Background:
- Congenital dyserythropoietic anaemias (CDA) are rare genetic disorders impacting red blood cell production.
- Characterized by abnormal erythroblasts and insufficient red blood cells, CDAs present clinically with varying onset and complications like iron overload.
Purpose of the Study:
- To review the classification and recent genetic discoveries in congenital dyserythropoietic anaemias.
- To highlight the progress in understanding the genetic basis of CDA I, II, and III.
Main Methods:
- Review of existing literature on CDA classification and genetic findings.
- Analysis of bone marrow morphology via light and electron microscopy for characterization.
- Genetic linkage analysis for gene localization.
Main Results:
- Three main types of CDA (I, II, III) are well-defined, with rare forms also reported.
- Gene loci for CDA I, II, and III have been localized to specific chromosomal regions (15q15.1-q15.3, 20q11.2, and 15q21-q25, respectively).
- Clinical evaluation refinement includes age of onset and iron overload determinants.
Conclusions:
- Genetic localization provides a foundation for future gene identification and epidemiological studies in CDAs.
- Further research is needed for definitive gene identification in CDA types.
Abstract:
Congenital dyserythropoietic anaemias (CDA) are a category of rare genetic diseases that affect erythropoiesis. Dyserythropoiesis is associated with abnormal erythroblasts and leads to altered red cells, the amount of which is insufficient. There are three main, well-defined CDAs, CDA I, II and III. Their characterization is based on a careful examination of the bone marrow under light and electron microscopes. In addition, a number of rare or unique forms of dyserythropoiesis have been reported. At least with respect to CDA I to III, the clinical evaluation is reaching an ever increasing refinement: age of discovery, determinants of iron overload and/or biliary complications. Over the past few years, a more promising breakthrough has been the localization of the genes responsible for CDA I, II and III, that is, 15q15.1-q15.3, 20q11.2 and 15q21-q25, respectively. Epidemiological studies have now become possible. The identification of the genes is pending.